УДК 378:147:013:61:355-504

Стаття присвячена особливостям використання інноваційних методів на заняттях з дисциплін кафедри медицини катастроф та військової медицини у процесі навчання надання домедичної допомоги в умовах воєнних дій. Аргументовано, що ключовим елементом втілення у навчальний процес освітніх інновацій є творча особистість викладача. Охарактеризовано інноваційні методи, які використовуються на заняттях під час вивчення дисциплін кафедри медицини катастроф та військової медицини. Підсумовано, що ефективне впровадження інноваційних методів у навчальний процес може значно підвищити якість підготовки майбутніх медичних фахівців та забезпечити їхню готовність діяти в екстремальних ситуаціях. Ключові слова: інноваційні методи; навчання; домедична допомога; симуляційне навчання; мультимедійні технології; проектні завдання; інтерактивні технології.

616.31:616.24(048.8)

Abstract. The article reviews the factors of dental exposure that may have a potential risk for the development of pulmonary diseases.

Objective. To analyze the current national and foreign literature on the relationship between dental health and pulmonary disease, while exploring current data and future research directions.

Materials and Methods. The study used analytical and bibliosemantic methods. The search for scientific infor- mation on the medical research topic was conducted in the databases of the following search engines: the electronic library of abstracts and theses of the Vernadsky National Library of Ukraine, PubMed, Medline, MedNet, Embase, BMJ Group, Free Medical Journals, Free Medical Book, Scirus.

Research results and discussion. The analysis of literature data provides evidence of a host-pathogen interac- tion associated with the oropharyngeal microbiome and its metabolites.

Cross-species interactions between microorganisms create a symbiotic relationship with the host macroorganism by acting as a "sensor", "mediator" and "killer" of pathogens to prevent pathogens from colonising and integrating into the host. Conversely, the immune response of the macroorganism must balance between inflammation to destroy the pathogen and prevent unwanted immune responses against host tissue and its own microorganisms. When the composi- tion, activity and function of the oral microbiome is disturbed, it causes dysbiosis. In the presence of orthopaedic struc- tures in the oral cavity, the eubiotic balance is more or less shifted to a pathogenic state.

The article analyses the influence of structural materials and methods of their production, which are mainly used in prosthetic dentistry, on the formation of biofilm, changes in the oral microbiome, and the spread of an inflammatory reaction in the prosthetic bed.

The oral cavity is the first line of defence of the immune system against most foreign pathogens, which can affect the immune and inflammatory reactions of the body as a whole. This factor can spread systemic inflammation that affects other organs, including the lungs. The oral microbiota can influence the microbial community in the lungs through mi- croaspiration and dispersal. In general, the oral-pulmonary axis can exchange components of its microbiome

The most common respiratory diseases associated with dust among dentists and its irritating effects on the res- piratory system are also analyzed.

In general, ultrafine and nanoscale airborne particles have been studied for a long time, but with the development of new technologies, their acute or chronic effects on the health of healthcare workers associated with dental practice require more detailed study.

Conclusion. Understanding the relationship between oral health and systemic diseases, including pulmonary diseases, and studying a multidisciplinary approach to the treatment of a particular disease can be important in terms of extending healthy life expectancy and improving its quality. For effective health management, it remains an unsolved issue whether it is possible to prevent systemic diseases by influencing oral diseases (and vice versa).

Keywords: microbiome, dysbiosis, bacterial adhesion, pulmonary diseases, oral health, biofilm, aerosols, nano- particles, prosthetic materials, cross-species interaction of microorganisms.

УДК 613.6:615.2:543.4

Анотація. Гідазепам – міжнародна непатентована назва активного фармацевтичного інгредієнта, на основі якого виготовляють лікарські препарати, що застосовуються як денні транквілізатори при невротичних, психопатичних астеніях, порушеннях сну і таке ін. В умовах фармацевтичного виробництва гідазепам може поступати у повітря робочої зони у вигляді аерозолю та негативно впливати на здоров’я працівників.

Метою роботи була розробка методики визначення гідазепаму у повітрі робочої зони, яка може застосовуватись для контролю гранично-допустимої концентрації речовини.

Матеріали та методи. Розробка методики здійснювалась з врахуванням вимог ДСТУ EN 482:2016. Фізико-хімічні властивості сполуки вивчались на основі літературних даних, метод та оптимальні умови вимірювання речовини встановлювались експериментально. Обрахунок робочих характеристик методики та невизначеності результату вимірювання проводили відповідно до вимог та рекомендацій Eurachem та санітарного законодавства України.

Результати дослідження. Гідазепам за хімічною будовою відноситься до похідних бензодіазипіну, є кристалічним порошком, що визначає його агрегатний стан у повітрі, а саме – аерозоль. Визначення гідазепаму виконували спектрофотометричним методом за λ = 283 нм, як розчинник використали розчин хлоридної кислоти з молярною концентрацією 0,1 моль/дм³. Відбір проб повітря проводили шляхом аспірації аерозолю речовини з вловлюванням на фільтр АФА-ХП-20 з об’ємною витратою 10,0 дм³/хв протягом 10,0 хвилин.

Встановлені робочі характеристики методики: робочий діапазон (мг/м³) ‒ 0,05-0,20; розширена невизначеність виміру (U, %) ‒ 17,5; збіжність (r, %) ‒ 6,6; показник проміжної прецизійності (rf, %) ‒ 9,0; показник відтворюваності (R, %) ‒ 16,0; показник стабільності градуювальної характеристики (K_гр, %) ‒ 6,0.

Висновки. Розроблено методику визначення гідазепаму у повітрі робочої зони, яка відповідає вимогам до референс-методик, що використовуються для контролю державних медико-санітарних нормативів. Використано спектрофотометричний метод, який базується на вимірюванні власного світлопоглинання розчину речовини в УФ-області спектра за λ = 283 нм. Встановлені робочі характеристики методики забезпечують належний рівень точності та можуть бути використані для оцінювання достовірності результатів вимірювань.

Ключові слова: гідазепам, повітря робочої зони, методика вимірювання, робочі характеристики.

Abstract. Gidazepam is the international non-proprietary name of the active pharmaceutical ingredient, on the basis of which drugs are manufactured that are used as daytime tranquilizers for neurotic, psychopathic asthenia, sleep disorders, etc. In the conditions of pharmaceutical production, hidazepam can enter the air of the working area in the form of an aerosol and negatively affect the health of workers.

The aim of the work was to develop a technique for determining gidazepam in the air of the working area, which can be used to control the maximum permissible concentration of the substance.

Materials and methods. The methodology was developed using the requirements of DSTU EN 482:2016. The physicochemical properties of the compound were studied on the basis of literature data, the method and optimal conditions for measuring the substance were established experimentally. Calculation the working characteristics of the method and the uncertainty of the measurement result was carried out in accordance with the requirements and recommendations of Eurachem and the sanitary legislation of Ukraine.

Research results. Gidazepam by its chemical structure belongs to benzodiazepine derivatives, by its aggregate state it is a crystalline powder, which determines its aggregate state in the air, namely, an aerosol. Hidazepam was determined by the spectrophotometric method at λ = 283 nm, using a solution of hydrochloric acid with a molar concentration of 0.1 mol/dm³ as a solvent. Air sampling was carried out by aspiration of an aerosol of the substance with capture on filter with a volumetric flow rate of 10.0 dm³/min for 10.0 minutes.

The established working characteristics of the technique: working range (mg/m³) ‒ 0.05-0.20; extended measurement uncertainty (U, %) ‒ 17.5;                   precision (r, %) ‒ 6.6; indicator of intermediate precision (r_f, %) ‒ 9.0; reproducibility index (R, %) ‒ 16.0; stability indicator of the grading                   characteristic (K_gr, %) ‒ 6.0.

Conclusions. A technique for determining gidazepam in the air of the working area has been developed, which meets the requirements for reference methods used to control state medical and sanitary standards. A spectrophotometric method was used, which is based on measuring the intrinsic light absorption of the substance solution in the UV region of the spectrum at λ = 283 nm. The established operating characteristics of the technique provide the appropriate level of accuracy and can be used to assess the reliability of measurement results.

Key words: hydazepam, air of the working area, measurement method, working characteristics.

UDC 616.24-002.5-036.22-085.28.015.8-085.37-039.71-053.2

Aim – to study the feasibility of using the natural immunomodulator BIVEL (BI-V) as a non-specific immunoprevention of tuberculosis (TB) among contact children from focies of multidrug-resistant tuberculosis infection (FsMDR-TBI) on the basis of clinical and immunological studies.
Materials and methods. The object of study: 120 contacted from FsMDR-TBI (75 children and 45 adolescents). The Group 1 – 95 children/adolescents who did not receive BI-V and the Group 2 – 25 patients who received BI-V. The state of phagocytic reactivity of immunity; cellular and humoral immunity; interleukins and specific immunity were determined. Statistical analysis of the obtained results was performed based on a software package Excel.
Results. In infected children/adolescents with FsMDR-TBI, insignificant functional disorders of the cellular response were revealed (decrease by 1.3 times IRI CD3+CD4+/CD3+CD8+), a shift in the balance in the regulatory system towards pro-inflammatory cytokines (increase by 2.0 times TNF-α/IL-10). The existing deviations in the regulatory and cellular response systems disappeared after the completion of the autumn-spring BI-V course. Preventive administration of immunomodulator BI-V to infected children/adolescents with FsMDR-TBI reduced the frequency of acute respiratory viral infections and exacerbations of bronchopulmonary diseases by 2.0 times, the development of latent tuberculosis infection into an active process by 2.6 times. Among children of the Group 2 – 8% of people fell ill with various forms of primary pulmonary TB, among children of the Group 1 – 22.1%. In both groups, the maximum level of TB occurred in the first two years of observation.
Conclusions. The introduction of the algorithm of preventive measures with appointment of BI-V confirmed feasibility of using this immunomodulator for contact children/adolescents with FsMDR-TBI.
The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethical 
Committee of the participating institution. The informed consent of patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Keywords: immunoprevention, contact children and adolescents, focies of multidrug-resistant tuberculosis.

УДК: 616.24-002.5:615.015.8]-085.281-078.73-036.8-053.2/6

BACKGROUND. The feasibility of combining antimycobacterial therapy (AMBT) with bedaquiline (Bdq) and delamanid 
(Dlm) with non-specific immunomodulator BI-V in children and adolescents with multidrug-resistant and rifampicin-resistant pulmonary tuberculosis (MDR/Rif-TBP) needs to be studied.
OBJECTIVE. To find out the effectiveness of the use of complex AMBT with Bdq and Dlm with non-specific immunomodulator BI-V in children and adolescents with MDR/Rif-TBP.
MATERIALS AND METHODS. Children and adolescents with MDR/Rif-TBP at the initial stage of AMBT were given BI-V 
(BIVEL, Slovenia) as a non-specific immunomodulator. The patients were divided into two groups: 1st – 20 patients who received Bdq + Dlm + levofloxacin (Lfx) + linezolid (Lzd) + clofazimine (Cfz); 2nd ‒ 28 patients whose complex treatment included BI-V (Вdq + Dlm + Lfx + Lzd + Cfz + BI-V). BI-V was prescribed from the age of 3 years at 5 ml suspension once a day during 24 days.
RESULTS. The use of BI-V against the background of individualized regimens of AMBT in children and adolescents with  MDR/Rif-TBP increased the effectiveness of treatment, contributed to the disappearance of symptoms of intoxication, the resolution of infiltration foci and the healing of decay cavities in system of immune protection, which contributed to the shortening of the inpatient stage of treatment, while maintaining a high therapeutic effectiveness (“cured” ‒ 92.8 %)  and the formation of small residual changes in the lungs in the majority (89.3 %).
CONCLUSIONS. When using combined complex AMBT with Bdq, Dlm and BI-V, high therapeutic efficiency was observed  in most patients (92.8 %).
KEY WORDS: multiple drug-resistant pulmonary tuberculosis, treatment, bedaquiline, delamanid, BI-V, children, adolescents